His campaign's issues page carries one health section, headed "TAKE ON BIG FOOD AND BIG PHARMA". It says Americans deserve transparency, accountability and the freedom to make informed choices about their health, and that in the Senate he will work with President Trump to take on pharmaceutical and food companies and increase transparency in food and health-care systems. It names no bill and no programme. His office's related actions in 2026 are investigations and settlements rather than legislation, including settlements requiring cereal brands to remove synthetic dyes and an investigation of an insurer over denied claims.
His campaign says health care is a human right and would let every American buy into Medicare at any age as a not-for-profit option, cap out-of-pocket drug costs and regulate pharmacy benefit managers, reverse this year's cuts to the Affordable Care Act credits, Medicare and Medicaid, reform prior authorisation, codify Roe v. Wade and protect contraception and IVF, and keep medical debt out of credit scores.
His campaign says health care is "a service, and like other goods and services, it should be provided by free-market competition", and blames the cost of care on federal intervention since the 1960s, naming Medicare and Medicaid, occupational licensing, regulation and the Food and Drug Administration. He would promote medical savings accounts, make health expenses tax-deductible, allow insurance to be bought across state lines, allow catastrophic-only policies, replace the FDA with private certification and allow drugs to be bought from other countries.
His campaign's health-care page says he passed two measures on drug costs in the Texas Legislature, one capping insulin copayments at $25 a month and one letting Texas import prescription drugs from Canada. Both measures are law and the figures are exact. HB 25 of the 88th Legislature, the wholesale prescription drug importation act, lists him as the first of five authors, with 117 coauthors and Senator Kolkhorst as its Senate sponsor; it took effect September 1, 2023, and Texas Legislature Online indexes it under CANADA. On insulin, SB 827 of the 87th Legislature took effect September 1, 2021, and its enrolled text bars a health plan from imposing a cost-sharing requirement where "the total amount the enrollee is required to pay exceeds $25 per prescription for a 30-day supply", which is the cap he describes. On that bill the Author field names Senator Kolkhorst and fourteen joint authors, and the House Sponsor field names two members, Lucio III and Talarico, in that order. Limit: The word doing the work is "passed", and it holds differently on the two bills. On the importation act he is the first-named author of a House bill that became law. On the insulin cap he is the second of the two House sponsors of a Senate bill someone else authored; unlike the single-name Sponsor field on a federal bill, the Texas record can and does name more than one sponsor, so it is able to record a co-lead and here it records him second. Neither bill is his alone, and both carry large bipartisan coauthor lists. Whether the importation programme has begun operating, and what either law has done to prices, are questions this card does not assess.